Opus Point Partners Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $217K | Hold |
5,064
| – | – | 0.39% | 52 |
|
|
2019
Q2 | $322K | Hold |
5,064
| – | – | 0.48% | 49 |
|
|
2019
Q1 | $351K | Sell |
5,064
-275
| -5% | -$19.1K | 0.48% | 49 |
|
|
2018
Q4 | $232K | Sell |
5,339
-795
| -13% | -$34.5K | 0.51% | 33 |
|
|
2018
Q3 | $468K | Sell |
6,134
-177
| -3% | -$13.5K | 1.12% | 26 |
|
|
2018
Q2 | $485K | Sell |
6,311
-980
| -13% | -$75.3K | 1.05% | 27 |
|
|
2018
Q1 | $372K | Sell |
7,291
-1,181
| -14% | -$60.3K | 0.73% | 31 |
|
|
2017
Q4 | $393K | Sell |
8,472
-3,427
| -29% | -$159K | 0.34% | 37 |
|
|
2017
Q3 | $634K | Buy |
11,899
+5,742
| +93% | +$306K | 0.57% | 37 |
|
|
2017
Q2 | $382K | Sell |
6,157
-6,044
| -50% | -$375K | 0.35% | 44 |
|
|
2017
Q1 | $827K | Buy |
12,201
+1,337
| +12% | +$90.6K | 0.61% | 35 |
|
|
2016
Q4 | $764K | Buy |
10,864
+3,790
| +54% | +$267K | 0.61% | 33 |
|
|
2016
Q3 | $502K | Hold |
7,074
| – | – | 0.28% | 35 |
|
|
2016
Q2 | $346K | Sell |
7,074
-6,426
| -48% | -$314K | 0.33% | 36 |
|
|
2016
Q1 | $855K | Buy |
+13,500
| New | +$855K | 0.66% | 33 |
|
|
2015
Q3 | – | Sell |
-9,000
| Closed | -$922K | – | 55 |
|
|
2015
Q2 | $922K | Sell |
9,000
-3,000
| -25% | -$307K | 0.73% | 34 |
|
|
2015
Q1 | $745K | Buy |
+12,000
| New | +$745K | 0.62% | 43 |
|